ATE58543T1 - Verfahren zur sulphatierung von glykosaminoglykanen, daraus hergestellte glykosaminoglykane und ihre biologischen verwendungen. - Google Patents

Verfahren zur sulphatierung von glykosaminoglykanen, daraus hergestellte glykosaminoglykane und ihre biologischen verwendungen.

Info

Publication number
ATE58543T1
ATE58543T1 AT86401563T AT86401563T ATE58543T1 AT E58543 T1 ATE58543 T1 AT E58543T1 AT 86401563 T AT86401563 T AT 86401563T AT 86401563 T AT86401563 T AT 86401563T AT E58543 T1 ATE58543 T1 AT E58543T1
Authority
AT
Austria
Prior art keywords
glycosaminoglycans
sulphatation
processes
manufactured therefrom
biological uses
Prior art date
Application number
AT86401563T
Other languages
English (en)
Inventor
Maurice Petitou
Jean Choay
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Application granted granted Critical
Publication of ATE58543T1 publication Critical patent/ATE58543T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
AT86401563T 1985-07-12 1986-07-11 Verfahren zur sulphatierung von glykosaminoglykanen, daraus hergestellte glykosaminoglykane und ihre biologischen verwendungen. ATE58543T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8510787A FR2584728B1 (fr) 1985-07-12 1985-07-12 Procede de sulfatation de glycosaminoglycanes et de leurs fragments
EP86401563A EP0214879B1 (de) 1985-07-12 1986-07-11 Verfahren zur Sulphatierung von Glykosaminoglykanen, daraus hergestellte Glykosaminoglykane und ihre biologischen Verwendungen

Publications (1)

Publication Number Publication Date
ATE58543T1 true ATE58543T1 (de) 1990-12-15

Family

ID=9321287

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86401563T ATE58543T1 (de) 1985-07-12 1986-07-11 Verfahren zur sulphatierung von glykosaminoglykanen, daraus hergestellte glykosaminoglykane und ihre biologischen verwendungen.

Country Status (13)

Country Link
US (1) US5013724A (de)
EP (1) EP0214879B1 (de)
JP (1) JPS6227402A (de)
AT (1) ATE58543T1 (de)
AU (1) AU607395B2 (de)
DE (1) DE3675717D1 (de)
DK (1) DK329886A (de)
ES (1) ES2001542A6 (de)
FR (1) FR2584728B1 (de)
GR (1) GR861811B (de)
NZ (1) NZ216835A (de)
PT (1) PT82974B (de)
ZA (1) ZA865240B (de)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8519416D0 (en) * 1985-08-01 1985-09-04 Unilever Plc Oligosaccharides
EP0300099A1 (de) * 1987-07-20 1989-01-25 Akzo N.V. Pentasaccharide
EP0333243A3 (de) * 1988-03-10 1989-09-27 Akzo N.V. Sulphatiertes K5-Antigen und seine Fragmente
FR2634485B1 (fr) * 1988-07-21 1992-02-28 Sanopi Glycosaminoglycanes selectivement o-acyles, leur preparation et compositions pharmaceutiques les contenant
US5340932A (en) * 1989-08-18 1994-08-23 Ajorca S.A. Substances with heparin-like structure and their method of production
EP0421508B1 (de) * 1989-10-04 1993-12-15 Akzo Nobel N.V. Sulfatierte Glykosaminoglykuronane mit antithrombotischer Wirkung.
IT1237518B (it) * 1989-11-24 1993-06-08 Renato Conti Eparine supersolfatate
FR2655267B1 (fr) * 1989-12-04 1992-04-03 Roussel Uclaf Nouveau derive sulfate du galactanne extrait de klebsiella, procede de preparation, application a titre de medicaments et compositions pharmaceutiques le renfermant.
US5158940A (en) * 1990-02-14 1992-10-27 The United States Government As Represented By The Secretary, Dhhs Use of suramin to treat rheumatologic diseases
WO1991015217A1 (en) * 1990-04-06 1991-10-17 Washington University Anticoagulant oligosaccharides
FR2669932B1 (fr) * 1990-12-03 1994-07-01 Sanofi Sa Nouvel heparosane-n,o-sulfate, son procede de preparation et les compositions pharmaceutiques qui le contiennent.
SE9101155D0 (sv) * 1991-04-18 1991-04-18 Kabi Pharmacia Ab Novel heparin derivatives
US5605938A (en) * 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
US5705178A (en) * 1991-05-31 1998-01-06 Gliatech, Inc. Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
IT1251183B (it) * 1991-08-28 1995-05-04 Opocrin Spa Dermatan solfato ad alto titolo, dotato di elevata attivita' trombolitica, e forme farmaceutiche che lo contengono.
AU2865692A (en) * 1991-10-04 1993-05-03 Virginia Commonwealth University Von willebrand factor-specific heparin fractions
US5714376A (en) * 1991-10-23 1998-02-03 Massachusetts Institute Of Technology Heparinase gene from flavobacterium heparinum
FR2684385B1 (fr) * 1991-11-28 1997-08-01 Sanofi Elf Heparosanes-n,o-sulfates de haute masse moleculaire, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
GB2266239B (en) * 1992-03-25 1996-03-06 Jevco Ltd Wound healing compositions containing chondroitin sulphate oligosaccharides
US5346997A (en) * 1992-08-26 1994-09-13 Murphy James G Agents for complexing sodium under biological conditions
AU4859793A (en) * 1992-09-11 1994-04-12 Regents Of The University Of California, The Sulfated ligands for l-selectins and use of chlorates and or sulfatases for the treatment of inflammation
US5695752A (en) * 1992-09-11 1997-12-09 The Regents Of The University Of California Treating inflammation via the administration of specific sulfatase enzymes and/or sulfation inhibitor
US5389539A (en) 1992-11-30 1995-02-14 Massachusetts Institute Of Technology Purification of heparinase I, II, and III from Flavobacterium heparinum
WO1994028889A1 (en) * 1993-06-08 1994-12-22 Neogenix, Inc. Purified natural and synthetic compounds for the treatment of osteoarthritis
PL177245B1 (pl) * 1993-09-30 1999-10-29 Seikagaku Kogyo Co Ltd Środek przeciwzakrzepowy
US5514665A (en) * 1993-12-30 1996-05-07 University Of British Columbia Method of preventing or reducing the risk of infection by bacterial pathogens utilizing simple and conjugated dextrans
ITPD940054A1 (it) * 1994-03-23 1995-09-23 Fidia Advanced Biopolymers Srl Polisaccaridi solfatati
US5639469A (en) * 1994-06-15 1997-06-17 Minnesota Mining And Manufacturing Company Transmucosal delivery system
WO1996001278A1 (en) * 1994-07-01 1996-01-18 Seikagaku Corporation Process for producing desulfated polysaccharide, and desulfated heparin
FR2729575B1 (fr) * 1995-01-24 1997-07-04 Elf Aquitaine Dispositif d'ionophorese pour l'administration transcutanee d'un principe actif de type glycosaminoglycane anionique de basse masse moleculaire
EP0754460B1 (de) * 1995-02-07 2002-06-05 Shiseido Company Limited Anti-inflamatorische agenzien
US5763427A (en) * 1995-03-31 1998-06-09 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US6001820A (en) * 1995-03-31 1999-12-14 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5744457A (en) * 1995-03-31 1998-04-28 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5646130A (en) * 1995-06-30 1997-07-08 Ocean University Of Oingdao Low molecular weight sulfated polysaccharides and uses thereof
US5980865A (en) * 1995-08-18 1999-11-09 Baker Norton Pharmaceuticals, Inc. Method for treating late phase allergic reactions and inflammatory diseases
CA2230385A1 (en) * 1995-09-05 1997-03-13 Cambridge Neuroscience, Inc. Analogs for specific oliogosaccharide-neuregulin interactions and uses thereof
US5922690A (en) * 1996-04-25 1999-07-13 Van Gorp; Cornelius L. Dermatan disulfate, an inhibitor of thrombin generation and activation
US5767269A (en) * 1996-10-01 1998-06-16 Hamilton Civic Hospitals Research Development Inc. Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics
IT1289613B1 (it) * 1997-02-07 1998-10-15 Inalco Spa Polisaccaridi batterici o-solfatati
IT1290814B1 (it) * 1997-03-24 1998-12-11 Istituto Scient Di Chimica E B Glicosaminoglicani aventi elevata attivita' antitrombotica
DE19813234A1 (de) * 1998-03-26 1999-09-30 Knoell Hans Forschung Ev Verfahren zur Herstellung hochsulfatierter Hyaluronsäuren
US6388060B1 (en) * 1998-11-06 2002-05-14 Vascular Therapeutics Inc. Process for the sulfation of uronic acid-containing polysaccharides
DE29900874U1 (de) * 1999-01-20 1999-07-22 Knoll AG, 67061 Ludwigshafen Organprotektive Lösungen
US6409987B1 (en) 1999-04-07 2002-06-25 Intimax Corporation Targeted agents useful for diagnostic and therapeutic applications
IT1306644B1 (it) 1999-04-08 2001-10-02 Fidia Advanced Biopolymers Srl Strutture tridimensionali comprendenti derivati dell'acido ialuronicoottenibili mediante la tecnica antisolvente supercritico.
EP1192187A1 (de) * 1999-06-30 2002-04-03 Hamilton Civic Hospitals Research Development, Inc. Heparinzusammensetzungen, die gerinnselzugehörige gerinnungsfakoren verhindert
US6518244B2 (en) 2000-03-09 2003-02-11 Intimax Corporation Combinations of heparin cofactor II agonist and platelet IIb/IIIa antagonist, and uses thereof
US20040038932A1 (en) * 2000-09-08 2004-02-26 Jack Hirsh Antithrombotic compositions
DK1319183T3 (da) * 2000-09-12 2009-05-18 Massachusetts Inst Technology Fremgangsmåder og produkter relateret til heparin med lav molekylvægt
DE10053053A1 (de) * 2000-10-19 2002-05-16 Knoell Hans Forschung Ev Pharmazeutische Formulierungen zur Hemmung von entzündlichen Arthritiden
KR20040066090A (ko) * 2001-08-31 2004-07-23 아이박스 리서치, 인코포레이티드 사카라이드를 황산화시키기 위한 방법
JP4828795B2 (ja) * 2002-03-11 2011-11-30 モメンタ ファーマシューティカルズ インコーポレイテッド 硫酸化多糖類の分析
FR2845686B1 (fr) * 2002-10-10 2013-08-30 Aventis Pharma Sa Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
AR043110A1 (es) * 2004-02-04 2005-07-20 Syntex Sa Sal de heparina de bajo peso molecular con trietanolamina util como agente terapeutico-antitrombotico de administracion topica, procedimientos para preparar dichas sales, proceso para la eliminacion de la higroscopicidad de la sal de heparina, composiciones farmaceuticas para uso topico en terapia a
JP4636818B2 (ja) * 2004-06-07 2011-02-23 マルホ株式会社 多硫酸化コンドロイチン硫酸の製造方法
US20060183712A1 (en) * 2005-02-17 2006-08-17 The Texas A&M University System Affinity purified heparin/heparan sulfate for controlling the biological activity of the FGF receptor
ATE552004T1 (de) 2005-11-30 2012-04-15 Istituto G Ronzoni Oral verabreichbare heparinderivate
US9139876B1 (en) 2007-05-03 2015-09-22 Momenta Pharmacueticals, Inc. Method of analyzing a preparation of a low molecular weight heparin
JP5758797B2 (ja) 2008-04-04 2015-08-05 ユニバーシティ・オブ・ユタ・リサーチ・ファウンデイション アルキル化半合成グリコサミノグリカンエーテルならびにその製造および使用方法
US8435795B2 (en) * 2010-01-19 2013-05-07 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
WO2012115952A1 (en) 2011-02-21 2012-08-30 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
US9522162B2 (en) 2011-03-23 2016-12-20 University Of Utah Research Foundation Methods for treating or preventing urological inflammation
US10000582B2 (en) 2013-04-02 2018-06-19 The Regents Of The University Of California Ethylsulfonated hyaluronic acid biopolymers and methods of use thereof
EP3279220B1 (de) 2015-03-31 2024-12-04 Seikagaku Corporation Verfahren zur sulfatierung von glykosaminoglykan
JP6757016B2 (ja) * 2016-03-16 2020-09-16 地方独立行政法人青森県産業技術センター 多硫酸化プロテオグリカン
US11337994B2 (en) 2016-09-15 2022-05-24 University Of Utah Research Foundation In situ gelling compositions for the treatment or prevention of inflammation and tissue damage
CN111228653A (zh) 2018-11-13 2020-06-05 格莱科米拉治疗公司 用电离辐射加强癌症治疗的方法
IT202000004564A1 (it) * 2020-03-04 2021-09-04 Lesaffre & Cie Processo per la solfatazione diretta di polisaccaridi in solvente ecologicamente accettabile

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB904112A (en) * 1958-12-19 1962-08-22 Roussel Uclaf Improvements in or relating to heparine and derivatives thereof
NL123338C (de) * 1961-12-08
US3211616A (en) * 1961-12-17 1965-10-12 Yosizawa Zensakn N, o-sulfated neutral-mucopolysaccharide
US4021544A (en) * 1976-07-12 1977-05-03 American Cyanamid Company Complement inhibitors
FR2374910A1 (fr) * 1976-10-23 1978-07-21 Choay Sa Preparation a base d'heparine, comprenant des liposomes, procede pour l'obtenir et medicaments contenant de telles preparations
IT1083903B (it) * 1977-08-09 1985-05-25 Lobo Srl Oligo-eteropolisaccaridi con attivita' eparinosimili,procedimento per il loro ottenimento e relative composizioni terapeutiche
DD136572B1 (de) * 1977-10-06 1980-12-24 Horst Toepfer Verfahren zur herstellung eines therapeutisch wirksamen mukopolysaccaridpolyschwefelsaeureesters aus rinder-trachea
SE7811306L (sv) * 1978-11-01 1980-05-02 Rothman Gunnvor Antikoagulationsmedel samt sett for dess framstellning
US4692435A (en) * 1978-11-06 1987-09-08 Choay, S.A. Mucopolysaccharide composition having a regulatory action on coagulation, medicament containing same and process of preparation
US4500519A (en) * 1978-11-06 1985-02-19 Choay S.A. Mucopolysaccharides having biological properties, preparation and method of use
US4281108A (en) * 1980-01-28 1981-07-28 Hepar Industries, Inc. Process for obtaining low molecular weight heparins endowed with elevated pharmacological properties, and product so obtained
FR2482611B1 (fr) * 1980-05-14 1986-03-07 Pharmindustrie Nouveaux polysaccharides sulfates, procedes pour leur preparation et leur utilisation comme medicaments
DE3020220A1 (de) * 1980-05-28 1981-12-03 Theodor Prof. Dr. 4400 Münster Eckert Organische salze des heparin, der heparinoide, ihre herstellung und sie enthaltende arzneimittel
DE3049445A1 (de) * 1980-12-30 1982-07-29 Theodor Prof. Dr. 4400 Münster Eckert "organische salze des heparin, der heparinoide, ihre herstellung und sie enthaltende arzneimittel"
FR2504928A1 (fr) * 1981-04-29 1982-11-05 Choay Sa Oligosaccharides a chaines courtes possedant des proprietes biologiques, leur preparation et leurs applications en tant que medicaments
SU981322A1 (ru) * 1981-05-08 1982-12-15 Московский Ордена Трудового Красного Знамени Текстильный Институт Им.А.Н.Косыгина Способ получени водорастворимого линейного полисахарида
FR2538404B1 (de) * 1982-12-28 1985-08-23 Anic Spa
FR2555993B1 (fr) * 1983-12-06 1986-11-07 Anic Spa Chitosanes 6-sulfates et procede pour leur preparation
CA1218986A (en) * 1982-12-28 1987-03-10 Annamaria Naggi Process for the depolymerisation and sulfatation of polysaccharides
US4710493A (en) * 1984-08-14 1987-12-01 Albert Landsberger Therapeutic agent for the use in cancer treatment

Also Published As

Publication number Publication date
ZA865240B (en) 1987-03-25
DE3675717D1 (de) 1991-01-03
AU607395B2 (en) 1991-03-07
EP0214879A3 (en) 1987-07-01
FR2584728B1 (fr) 1987-11-20
EP0214879A2 (de) 1987-03-18
EP0214879B1 (de) 1990-11-22
JPS6227402A (ja) 1987-02-05
PT82974A (fr) 1986-08-01
DK329886D0 (da) 1986-07-11
NZ216835A (en) 1989-03-29
US5013724A (en) 1991-05-07
AU6009986A (en) 1987-01-15
PT82974B (pt) 1988-07-01
ES2001542A6 (es) 1988-06-01
DK329886A (da) 1987-01-13
GR861811B (en) 1986-11-04
FR2584728A1 (fr) 1987-01-16

Similar Documents

Publication Publication Date Title
ATE58543T1 (de) Verfahren zur sulphatierung von glykosaminoglykanen, daraus hergestellte glykosaminoglykane und ihre biologischen verwendungen.
DE3574931D1 (de) Verfahren und anlage zur herstellung von sterilem wasser und sterilen waessrigen loesungen.
DE3674815D1 (de) Waessriges haftgel und verfahren zu seiner herstellung.
ATE8203T1 (de) Antineoplastische mittel auf basis von nicht oder nur geringfuegig irritierenden und/oder promovierenden diterpenalkoholen und derivaten davon und deren herstellung.
DE3486052D1 (de) Verfahren zur unabaenderlichen bindung von proteinen auf polystyren-oberflaechen mit aufrechterhaltung ihrer biologischen wirksamkeit, derart erhaltene polystyren-oberflaechen und ihre verwendung.
AT379811B (de) Verfahren zur herstellung von neuen chinolinen, chinoxalinen und chinazolinen und deren pharmazeutisch verwendbaren derivaten
ATE40147T1 (de) Waessriges elektrotauchlack-ueberzugsmittel und dessen verwendung zum beschichten von gegenstaenden.
DE3683729D1 (de) Gegenstand und verfahren zur enzymatischen neutralisierung von wasserstoffperoxyd.
ATA308986A (de) Menschliche mangan-superoxiddismutase cdna, ihre expression in bakterien und verfahren zur gewinnung enzymatisch aktiver, menschlicher mangan-superoxiddismutase
DE3777618D1 (de) Elektroabscheidungsverfahren und waesserige harz-lackzusammensetzung.
DE3750025D1 (de) Zytostatisch wirksame Anthracyclinderivate.
DE3860578D1 (de) Verfahren fuer die selektive reduktion von wassereindringungen in oel- oder gasquellen.
PT67829A (de) Praeparat zur behandlung von herpes zoster und anderen herpes-infektionen,sowie verfahren zu seiner herstellung
DE3783751D1 (de) Glyzirrhetinsaeure-derivate und ihre anwendung.
ATA672878A (de) Mittel zur stabilisierung von enzymen
DE3788300D1 (de) Pharmazeutisches Präparat zur Verhütung der Schädigung lebender Zellen durch freie Radikale, beziehungsweise zur Erhöhung der Wirksamkeit von organischen Schwefelverbindungen und Verfahren zur Erhöhung der Lebensdauer isolierter Organe.
ATE50986T1 (de) Verfahren und zwischenprodukte von derivaten von 16-phenoxy und 16-phenoxy-substitutierter prostatriensaeure und ihre stereoisomere.
AT386225B (de) Verfahren zur hestellung von 17-c-steroid-alpha- propionsaeureverbindungen, insbesondere von 3-oxopregna-4-en-20-carbons|ure und/oder 3-oxo-pregna-1,4-dien-20-carbonsaeure
ATE2150T1 (de) Verfahren zur herstellung von cholestenderivaten und neue zwischenprodukte in deren herstellung.
ATA559778A (de) Verfahren zur herstellung von neuen 1,2- -benzisothiazolen und deren saeureadditions- salzen
ES552738A0 (es) Procedimiento de tratamiento para la conservacion de generos perecederos que presentan vacios o poros, como los champinones, y dispositivo para su puesta en practica
FI880597A7 (fi) Menetelmä vesipitoisten öljylietteiden tai vastaavien lämpökäsittelyä varten.
ATE49001T1 (de) Verfahren zur herstellung von milbemycinderivaten und einige in diesem verfahren verwendete derivate.
ATE16057T1 (de) Verfahren zur herstellung von elektroden fuer elektrochemische apparate, die eine waessrige loesung oder dgl. verwenden.
OA08144A (fr) La triade soc, steo1, INS dans le traitemant de la stérilité masculine.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee